Literature DB >> 17071927

Mutations in progranulin explain atypical phenotypes with variants in MAPT.

Stuart M Pickering-Brown, Matt Baker, Jenny Gass, Bradley F Boeve, Clement T Loy, William S Brooks, Ian R A Mackenzie, Ralph N Martins, John B J Kwok, Glenda M Halliday, Jillian Kril, Peter R Schofield, David M A Mann, Mike Hutton.   

Abstract

Mutations in presenilin-1 (PSEN1) cause autosomal dominant Alzheimer's disease and mutations in MAPT cause the familial tauopathy Frontotemporal dementia linked to chromosome 17 (FTDP-17). However, there have been reports of mutations in PSEN1 and MAPT associated with cases of FTD with ubiquitin-positive tau-negative inclusion pathology. Here, we demonstrate that the MAPT variants are almost certainly rare benign polymorphisms as all of these cases harbour mutations in Progranulin (PGRN). Mutations in PGRN were recently shown to cause ubiquitin-positive FTDP-17.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071927     DOI: 10.1093/brain/awl289

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  31 in total

1.  Late-onset frontotemporal dementia associated with a novel PGRN mutation.

Authors:  A Lladó; R Sánchez-Valle; R Reñé; M Ezquerra; M J Rey; E Tolosa; I Ferrer; J L Molinuevo
Journal:  J Neural Transm (Vienna)       Date:  2007-04-10       Impact factor: 3.575

2.  Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.

Authors:  Johannes Carolus Magnus Schlachetzki; Klaus Schmidtke; Jan Beckervordersandforth; Wiktor Borozdin; Christian Wilhelm; Michael Hüll; Jürgen Kohlhase
Journal:  J Neurol       Date:  2009-07-19       Impact factor: 4.849

Review 3.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 4.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β.

Authors:  Xue Gao; Alvin P Joselin; Lei Wang; Amar Kar; Payal Ray; Andrew Bateman; Alison M Goate; Jane Y Wu
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

6.  The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

Authors:  Chang-En Yu; Thomas D Bird; Lynn M Bekris; Thomas J Montine; James B Leverenz; Ellen Steinbart; Nichole M Galloway; Howard Feldman; Randall Woltjer; Carol A Miller; Elisabeth McCarty Wood; Murray Grossman; Leo McCluskey; Christopher M Clark; Manuela Neumann; Adrian Danek; Douglas R Galasko; Steven E Arnold; Alice Chen-Plotkin; Anna Karydas; Bruce L Miller; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Vivianna M Van Deerlin
Journal:  Arch Neurol       Date:  2010-02

Review 7.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 8.  Frontotemporal Dementia.

Authors:  Roger E Kelley; Ramy El-Khoury
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

9.  Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia.

Authors:  Maura Gallo; Carmine Tomaino; Gianfranco Puccio; Francesca Frangipane; Sabrina A M Curcio; Livia Bernardi; Silvana Geracitano; Maria Anfossi; Maria Mirabelli; Rosanna Colao; Franca Vasso; Nicoletta Smirne; Raffaele G Maletta; Amalia Cecilia Bruni
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

10.  Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.

Authors:  NiCole Finch; Matt Baker; Richard Crook; Katie Swanson; Karen Kuntz; Rebecca Surtees; Gina Bisceglio; Anne Rovelet-Lecrux; Bradley Boeve; Ronald C Petersen; Dennis W Dickson; Steven G Younkin; Vincent Deramecourt; Julia Crook; Neill R Graff-Radford; Rosa Rademakers
Journal:  Brain       Date:  2009-01-21       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.